Predictors of Hospital Outcome and Intubation of Patients Hospitalized for Exacerbation of Chronic Obstructive Pulmonary Disease

Document Type : Original Article

Authors

1 Department of Chest Diseases ,Faculty of Medicine, Al-Azhar University,Cairo,Egypt

2 Chest Diseases, Al-Azhar University.

3 Department of Chest Diseases,Faculty of Medicine,Al-Azhar University,Cairo,Egypt

Abstract

Background: exacerbations of COPD affect a significant number of patients. Severe exacerbations are linked to worse outcome.
Aim of work: To identify predictors of adverse outcomes in patients who were admitted to the hospital for exacerbation of COPD.
Patients and methods: The present study was conducted on 120 patients with COPD at Chest diseases Departments and ICUs of Al Azhar University Hospitals in the period from March 2019 to March 2021.
Results: patients need mechanical ventilation had ischemic heart disease with hypertension p = 0.034, old ischemic stroke with hypertension p= 0.001, old hemorrhagic stroke with hypertension p = 0.001, exposure to air pollution p = 0.037,exposure to pneumonia p = 0.038, increase previous exacerbations (p = 0.001), admission on exacerbation (p = 0.001) and intubation last 5 years (p < /p>

Keywords


INTRODUCTION

Chronic obstructive pulmonary disease (COPD) is third cause of death in the world. Exacerbations of COPD affect a significant number of patients. Severe exacerbations are linked to worse outcome.1

An adverse outcome of COPD exacerbation, characterized by the presence of at least one of the following items: mortality from a respiratory cause during hospitalization or within one month of follow-up; admission to Intensive care unit (ICU); mechanical ventilation, invasive or non-invasive; prolonged hospitalization, defined by the upper quartile of hospital stay distribution, and emergency room visit or readmission due to COPD during follow-up. Absence of all the above-mentioned problems considers good outcome. 2

The need for invasive ventilation and complications due to mechanical ventilation (MV) are the most important predictors connected to hospital mortality in COPD exacerbation. Adequate metabolic compensation for respiratory acidosis at admission is linked with better outcome.3

The aim of this study to identify predictors of adverse outcomes in patients who were admitted to the hospital for exacerbation of COPD.

PATIENTS AND METHODS

This study was done at Chest diseases Departments of Al Azhar University Hospitals at March 2019 to March 2021.This study included 120 hospitalized patients with COPD. The patients were divided to 3 groups: Group I: patients with no need for MV.  Group II: patients needed   noninvasive MV. Group III: patients needed   invasive MV.

 A written informed consent were obtained from all the studied patients. All patients were subjected to full medical history, full physical examinations, laboratory investigation, calculation of Chronic obstructive pulmonary disease severity score (COPDSS) 4   , calculation of the Glasgow Coma Scale and spirometry including forced expiratory volume in 1 second (FEV1), forced vital capacity (FVC) and FEV1/FVC.

Data   were analyzed by the Statistical Package for Social Science (IBM SPSS) version 20. Quantitative data were expressed as mean± standard deviation (SD). Qualitative data were expressed as frequency and percentage. The following tests were done: Chi-square test was used to compare between two groups with qualitative data. The comparison between more than two groups with quantitative data and parametric distribution were done by using One Way Analysis of Variance (ANOVA) test. The p-value was considered significant as the following : P > 0.05: Non-significant (NS), P < 0.05: Significant (S), P < 0.01: Highly significant (HS).

 

RESULTS

 

Hospital course

Patients improved

(No.=84)

Patients need

noninvasive ventilation

(No.=22)

Patients need

invasive ventilation

(No.=14)

Chi square test

No

%

No

%

No

%

x2

p value

Sex

Female

6

7.1%

5

22.7%

6

42.9%

14.211

0.001

Male

78

92.9%

17

77.3%

8

57.1%

Smoking status

Non smoker

7

8.3%

4

18.2%

6

42.9%

12.120

0.002

smoker

49

58.3%

12

54.5%

8

57.1%

0.103

0.950

Ex-smoker

28

33.3%

6

27.3%

0

0.0%

6.581

0.037

Comorbidities

Ischemic heart disease with hypertension

1

1.2%

2

9.1%

2

14.3%

6.789

0.034

Old ischemic stroke with hypertension

2

2.4%

1

4.5%

4

28.6%

15.066

0.001

Old hemorrhagic stroke with hypertension

1

1.2%

0

0.0%

2

14.3%

9.133

0.001

Hypertension

22

26.2%

3

13.6%

0

0%

5.837

0.054

Diabetes mellitus

4

4.8%

1

4.5%

0

0%

0.691

0.708

No comorbidities

11

13.1%

1

4.5%

1

7.1%

1.543

0.462

 

Previous exacerbations

44

52.4%

13

59.1%

14

100%

11.263

0.001

Hospitalization for COPD exacerbation

42

50.0%

10

45.5%

14

100%

13.113

0.001

Intubation last 5 years

6

7.1%

1

4.5%

6

42.9%

16.948

<0.001

Risk factors

Air pollution

8

9.5%

6

27.3%

4

28.6%

6.597

0.037

Pneumonia

36

42.9

3

13.6%

6

42.9%

6.545

0.038

Age

Mean

SD

Mean

SD

Mean

SD

 

 

64.02

6.31

64.64

6.51

66.57

9.92

0.843

0.433

 

Table 1: characteristics of patients according to hospital course.

This table shows that there was statistically significant increase male, non-smoker and ex-smoker in patients improved. There was statistically significant increase in ischemic heart disease with hypertension, old ischemic stroke and old hemorrhagic stroke with hypertension. There was statistically significant increase in previous exacerbations, hospitalization for COPD exacerbation and intubation last 5 years in patients need invasive ventilation. There was statistically significant increase   in air pollution and pneumonia   in patients needed ventilation.

 

Hospital course

Patients improved

(No.=84)

Patients need

noninvasive ventilation

(No.=22)

Patients need

invasive ventilation

(No.=14)

Chi square test

No

%

No

%

No

%

x2

p value

Clinical characters

Cough

52

61.9%

6

27.3%

12

58.3%

13.49

0.001

Dyspnea

51

60.7%

6

27.3%

11

78.6%

11.037

0.004

Fever

20

23.8%

11

50.0%

3

21.4%

6.261

0.044

Vital signs

 

Mean

SD

Mean

SD

Mean

SD

 

 

Respiratory Rate, breath/min

24.96

2.83

24.09

3.13

28.14

5.05

7.426

0.001

Heart Rate, beat/min

92.00

11.39

91.86

8.81

98.64

14.49

2.129

0.124

Systolic blood pressure, mmHg

132.98

16.13

128.64

17.26

110.71

22.00

10.227

<0.001

Diastolic blood pressure, mmHg

83.69

8.92

81.82

10.97

72.14

13.11

8.238

<0.001

Temperature, °C

36.71

0.74

36.81

0.98

36.87

0.92

0.312

0.733

 

Table 2: clinical characters and vital signs among studied groups.

There was statistically significant increase in dyspnea in patients needed ventilation. There was statistically significant increase respiratory rate in patients need invasive ventilation. There was statistically significant increase systolic blood pressure and diastolic blood pressure in patients improved.

 

Patients improved

(No.=84)

Patients need

noninvasive ventilation

(No.=22)

Patients need

invasive ventilation

(No.=14)

 

 

Mean

SD

Mean

SD

Mean

SD

One way ANOVA

p value

Glasgow Coma Score(GCS)

14.48

1.52

13.91

1.54

10.00

2.60

42.54

< 0.001

COPD Severity score (COPDSS)

13.00

2.08

13.45

2.06

14.57

1.70

3.675

0.028

ABG

Arterial pH

7.36

0.06

7.27

0.07

7.28

0.11

18.254

< 0.001

PaO2, mmHg

61.04

24.57

64.64

24.61

46.86

21.93

2.525

0.084

PaCo2, mmHg

50.09

9.87

76.18

16.22

65.50

16.69

44.516

< 0.001

HCO3, mEq/L

28.05

5.17

32.22

7.74

31.93

8.54

5.493

0.005

Spirometry

FEV/FVC

0.63

0.06

0.61

0.06

0.59

0.04

4.962

0.009

FVC

73.45

6.62

72.41

3.89

68.29

2.46

4.669

0.011

FEV1

46.37

5.42

44.32

4.65

40.07

3.45

9.587

< 0.001

Chest

 X-ray

 

No

%

No

%

No

%

Chi square test

p value

Hyperinflation

58

69%

17

77.2%

8

57.1%

1.627

0.443

Left   Pleural effusion

0

0%

0

0%

1

7.1%

7.633

0.022

Bronchiectasis

0

0%

0

0%

1

7.1%

7.635

0.022

This table shows that there was statistically significant increase COPDSS, PaCo2, HCO3 and respiratory rate in

Table 3: Glasgow Coma Score, COPD Severity score (COPDSS), ABG, spirometry & chest x ray findings among studied patients.

patients need invasive ventilation. Also there was statistically significant increase in left pleural effusion and bronchiectasis in patients need mechanical ventilation. While there was an increase in GSC, arterial pH and spirometry valuesin patients improved.

 

 

Item

No.

%

Indications of intubations

Apnea

3

21.4

Low Glasgow coma score

5

35.7

Acute cardio vascular instability

2

14.3

Failure of NIV with confusion

3

21.4

Indications of intubation at time of admission

Low Glasgow coma score

4

66

Apnea

2

33

 

Number of intubated patients at time of admission

6

 42%

Table 4: Intubations among studied patients.

This table shows that most of studied patients were intubated due to low Glasgow coma score and 42% of the intubated patients were intubated at time of admission.

 

Patients improved

(No.=84)

Patients need

noninvasive ventilation(No.=22)

Patients need

invasive ventilation(No.=14)

Total

Test

p-value

 

No.

%

No.

%

No.

%

No.

%

 

 

Discharge

77

91.7

21

95.9

4

28.6

102

85

39.7

000

Readmission

7

8.3

1

4.5

6

42.9

14

11.7

15.2

000

Death

0

0

0

0

4

28.6

4

3.3

31.3

000

Table 5: Outcome among all studied groups.

This table shows that there was high significance increase regarding discharge in patients improved and there was high significance increase regarding readmission and death in patients needed ventilation.

 

DISCUSSION

We studied 120 patients with COPD. Their mean age is 64.43±6.83 years old. This is correlating with reports from Ucgun et al in which mean age was 65.1 years. 3 85.8% of them were male. This result agrees with the results of several studies. 3, 5 the high prevalence of COPD in men is due to higher prevalence of smoking in this sex, and males are also more exposed to smoking than females. 6

Regarding smoking status 57.5% of patients were smokers, 28.3% of them were ex-smoker which is coping with results of the study done by Said et al. 7Approximately 50% of smokers developing COPD during their lifetime .8

 In the present study patients were divided according to hospital course to three groups group I including 84 (70%) of studied patients who were improved, group II including 22 (18.3%) of studied patients who needed noninvasive ventilation and group III including 14 (11.7%) of studied Patients who needed invasive ventilation.

Our results indicated that patients suffered from ischemic heart disease with hypertension, old ischemic stroke and old hemorrhagic stroke with hypertension had bad hospital course which is coping with several studies that showed that patients with bad outcome of COPD exacerbation had more than two comorbidities, mostly cardiovascular comorbidities.5, 9 Anzueto et al   reported that cardiovascular comorbidities are risk factors for bad outcome in COPD patients. 9

 Table 1shows that there were statistically significant increase previous exacerbations (p value 0.001), hospitalization for COPD exacerbation (p value 0.001) and intubation last 5 years (p value <0.001) in patients need invasive ventilation. That is consistent with the results of Soler et al   whitch shows increased risk of death with frequent exacerbations. 10These results can be explained by the increase of severity of exacerbations over time, and also sputum purulence increases throughout the disease. This suggests that patients with more severe exacerbations have more inflammation. 11

56.6% of patients were presented with dyspnea at admission, this finding is similar to results from Mohan et al. 12 In this work most of patients were presented with cough and dyspnea, reports from Grolimund et al    and roche et al   agreed with these results. 13, 14

Table 2 shows as regard to risk factors of COPD exacerbations among all studied groups there was statistically significant increase   in air pollution and pneumonia   in patients needed ventilation with p value of 0.037 and 0.038 respectively that may be due to complications of pneumonia and presence of air pollution that worsen the lung function.

As regard COPDSS there was statistically significant increase COPDSS in patients need invasive ventilation. Miravitlles et al   showed that COPDSS was found to be a predictor for failure of treatment in COPD exacerbation.4

In this study ABG was statistically significant in patients need MV as regard lower PH and higher Co2, this correlate with results from Matkovic et al that assumed that ABG analysis had a high predictive value for outcome for patients hospitalized for COPD exacerbation5, also this result is coping with several studies that shows that higher Co2 was related to bad outcome of COPD patients. 15

In the current study the mean of FEV1/FVC was 0.62, mean of FVC was 72.66, mean of FEV1 was 45.26. There was statistically significant increase in spirometry values in patients improved, that is consistent with study by Matkovic et al which shows there is increased spirometry values in patients with good outcome. 5 Similar results have been found in many studies and may be explained by the degree of ventilatory impairment and also exposure to the risk of colonization by aggressive bacteria which causes exacerbation.16

Our study shows that 14 patients needed intubation. 35.7% of them was intubated due to Low Glasgow coma score, while 21.4% of patients was intubated due to apnea and 21.4% was intubated due to Failure of NIV with confusion that is coping with. 3 In this work 6 patients were intubated at time of admission. 66% was intubated due to low Glasgow coma score, 33% of them was intubated due to apnea.

Our results indicate that as regard outcome of all studied groups there was high significance increase regarding discharge in patients improved (p value 0.000) and there was high significance increase regarding readmission and death in patients needed ventilation (p value 0.000). That is coping with results of Mohan et al. 12The lowest readmission rate (4.5%) was with patients needed NIV. this result is attributed to that NIV increases alveolar ventilation and improves gas exchanges. also NIV reduces the patients’ effort, dyspnea, the need for intubation, length of stay in ICU and the mortality rate. 17

CONCLUSION

The need for invasive ventilation and complications due to mechanical ventilation (MV) are the most important predictors connected to hospital mortality in COPD exacerbation. Comorbidities with Cardio vascular diseases, previous exacerbations, hospitalization for COPD exacerbation, intubation last 5 years, exposure to air pollution and pneumonia, dyspnea at time of admission, increase COPDSS and increase respiratory rate, pleural effusion, and bronchiectasis had highest risks to invasive ventilation. There was increase regarding readmission and death in patients needed ventilation.

REFERENCES
1-Viniol, Christian; Vogelmeier, Claus F. Exacerbations of COPD. European Respiratory Review. 2018; 27(147‏).‏ https://doi.org/10.1183/16000617.0103-2017
2- Rothberg M., Pekow P., Lahti M., Brody O., Skiest D. ,et al. Antibiotic therapy and treatment failure in patients hospitalized for acute exacerbations of chronic obstructive pulmonary disease. Jama. 2010; 303(20):2035–42.‏ https://doi.org/10.1001/jama.2010.672
3- Uncgun I., Metintas M., Moral H., Alatas F., Yildirim H., et al. Predictors of hospital outcome and intubation in COPD patients admitted to the respiratory ICU for acute hypercapnic respiratory failure. Respiratory medicine.2006; 100(1), 66-74.‏ https://doi.org/10.1016/j.rmed.2005.04.005
4- Doll H., & Miravitlles M. . COPD severity score as a predictor of failure in exacerbations of COPD. The ESFERA study. Respiratory medicine. 2011; 105(5), 740-7.‏ https://doi.org/10.2165/00019053-200523040-00005
5- Matkovic Z., Huerta A., Soler N., Domingo R., Gabarrús  A.,et al. Predictors of adverse outcome in patients hospitalised for exacerbation of chronic obstructive pulmonary disease. Respiration.2012; 84(1), 17-26.‏ https://doi.org/10.1159/000335467
6-Han M., Postma D., Mannino D., Giardino N., Buist S., et al. Gender and chronic obstructive pulmonary disease: why it matters. American journal of respiratory and critical care medicine.2007; 176(12), 1179-84.‏ https://doi.org/10.1164/rccm.200704-553CC
7- Said A., Ewis A., Omran A., Magdy M., & Saleeb M. Prevalence and predictors of chronic obstructive pulmonary disease among high-risk Egyptians. Egyptian Journal of Bronchology.2015; 9(1), 27-33.‏ https://doi.org/10.4103/1687-8426.153586
8- Eisner M. D., Omachi T. A., Katz P. P., Yelin E. H., Iribarren C., et al. Measurement of COPD severity using a survey-based score: validation in a clinically and physiologically characterized cohort. Chest.2010; 137(4), 846-51.‏ https://doi.org/10.1378/chest.09-1855
9- Anzueto A., Leimer I.; Kesten S. Impact of frequency of COPD exacerbations on pulmonary function, health status and clinical outcomes. International journal of chronic obstructive pulmonary disease.2009; 4(245).‏ https://dx.doi.org/10.2147%2Fcopd.s4862
10-Soler-Cataluña J., Martínez-García M., Sánchez L., Tordera M., & Sánchez P. R, et al. Severe exacerbations and BODE index: two independent risk factors for death in male COPD patients. Respiratory medicine.2009; 103(5), 692-9.‏ https://doi.org/10.1016/j.rmed.2008.12.005
11- Donaldson G., Seemungal T., Bhowmik A., & Wedzicha J. A.Relationship between exacerbation frequency and lung function decline in chronic obstructive pulmonary disease. Thorax.2002; 57(10), 847-52.‏ DOI: 10.1136/thorax.57.10.847
12- Mohan A., Premanand R., Reddy L., Rao M., Sharma S., et al. Clinical presentation and predictors of outcome in patients with severe acute exacerbation of chronic obstructive pulmonary disease requiring admission to intensive care unit. BMC pulmonary medicine.2006; 6(1), 1-8.‏ https://doi.org/10.1186/1471-2466-6-27
13- Grolimund E., Kutz A., Marlowe R., Vögeli A., Alan M., et al. Long-term prognosis in COPD exacerbation: role of biomarkers, clinical variables and exacerbation type. COPD: Journal of Chronic Obstructive Pulmonary Disease. 2015; 12(3), 300-10.‏ https://doi.org/10.3109/15412555.2014.949002
14- Roche N., Chavaillon J., Maurer C., Zureik M., & Piquet J. A clinical in-hospital prognostic score for acute exacerbations of COPD. Respiratory research.2014; 15(1), 1-8.‏ https://doi.org/10.1186/s12931-014-0099-9
15- Groenewegen K., Schols A., & Wouters E. Mortality and mortality-related factors after hospitalization for acute exacerbation of COPD. Chest.2003; 124(2), 459-467.‏https://doi.org/10.1378/chest.124.2.459
16- Flattet Y., Garin N., Serratrice J., Perrier A., Stirnemann J., et al.  Determining prognosis in acute exacerbation of COPD. International journal of chronic obstructive pulmonary disease.2017; 12: 467.‏ https://dx.doi.org/10.2147%2FCOPD.S122382
17- Doll H. & Miravitlles M. Health-related QOL in acute exacerbations of chronic bronchitis and chronic obstructive pulmonary disease. Pharmacoeconomics.2005; 23(4), 345-63.‏ https://doi.org/10.2165/00019053-200523040-00005